Covid-19’s Limited Impact on Drug Shortages in Canada
Bibliographic Data
| ID | 11969895 |
|---|---|
| Authors | Étienne Gaudette (0000-0003-0359-2083, University of Toronto, corresponding author) |
| Year | 2020 |
| Volume | 46 |
| Issue | S3 |
| Pages | S307-S312 |
| Publication date | 2020-08-31 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Canadian Public Policy (JOURNAL) |
| Journal identifiers | ISSN: 0317-0861 • E-ISSN: 1911-9917 |
| Publisher | University of Toronto Press Inc. (UTPress) (PUBLISHER) |
| DOI | 10.3138/cpp.2020-107 |
| PMID | 38629995 |
| OpenAlex | W3081616766 |
| Language | EN |
| Citations received | 1 |
| References cited | 4 |
Using data from the Drug Shortages Canada website, we ask whether the first months of the coronavirus disease 2019 (COVID-19) pandemic were associated with a significant increase in drug shortages in Canada. We find an increase of 147 shortages (32 percent) reported by manufacturers during March and April 2020 relative to the same months in previous years. The upsurge was concentrated during the two-week period from 25 March to 7 April 2020, after which report counts returned to usual levels. Excess reports cite both supply-side and demand-side causes for shortages. Increases were noted in therapeutic classes associated with COVID-19 care
2019-20 coronavirus outbreak · Business · Coronavirus disease 2019 (COVID-19 · Disease · Drug · Economic shortage · Environmental health · Infectious disease (medical specialty · Outbreak · Pandemic · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 · Sociology · Demography · Health Systems, Economic Evaluations, Quality of Life · Medicine · Pharmaceutical Economics and Policy · Pharmaceutical industry and healthcare · Internal Medicine · Pharmacology · Virology
| Citations per year | 0.33 |
|---|---|
| Citation span | 2023 - 2023 (1) |
| Highly cited | No |